In his 2016 budget proposal, President Barack Obama seeks $31.3 billion for the National Institutes of Health (NIH), an increase of $1 billion over 2015 levels. The proposal also announces a Precision Medicine initiative, calling for $216 million in 2016 for efforts at NIH, the Food and Drug Administration (FDA) and the Office of the National Coordinator for Health Information Technology. This initiative is intended “to develop prevention, diagnostic, and treatment approaches tailored to individual patients,” officials note. Elsewhere, the budget proposes $1.2 billion for federal programs to combat and prevent antibiotic resistance, with those resources shared among NIH, FDA, the Centers for Disease Control and Prevention and the Biomedical Advanced Research and Development Authority, as well as the Departments of Veterans Affairs and Defense. Amid these proposals to support biomedical research, Washington, DC–based Biotechnology Industry Organization says that parts of the proposed 2016 budget that call for reducing the period of regulatory data protection for innovative biologics as well as several proposed changes to Medicare “will directly undermine other initiatives and activities contained within the President's budget and which we find critically important.”